Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom
Pearson, I., Hawe, E., Zuluaga Sanchez, S., Wolowacz, S., & Haiderali, A. (2015). Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom. Value in Health, 18(7), A455. https://doi.org/10.1016/j.jval.2015.09.1159
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.